Search
for
Sort by
Research 361–390 of 1000+
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia
- JAK-inhibitors in the therapy of comorbid diseases – atopic dermatitis and alopecia areata: literature review and experience of clinical practice
- Alopecia – New building blocks
- Hair regrowth in a patient with central centrifugal cicatricial alopecia after a 2-month trial of baricitinib
- Adverse events in patients treated with Jak‐inhibitors for alopecia areata: A systematic review
- Alopecia Areata Barbae in a Nutshell
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Response to “Reply to effectiveness of dutasteride in a large series of patients with FFA in real clinical practice”
- Topical tofacitinib in treatment of alopecia areata
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Alopecia areata
- Hair Follicle Reconstruction and Stem Cells
- Two Birds that Exclude Each Other: The Renbök Phenomenon
- A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol
- Dermal T cell immunity and key regulatory signaling pathways: Implications in immune-mediated alopecia and hair regeneration
- Alopecia areata-like hair loss after a tick bite
- Improvement of Recalcitrant Dissecting Cellulitis of the Scalp After a Trial of Upadacitinib
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Clinical Outcomes for Uptitration of Baricitinib Therapy in Patients With Severe Alopecia Areata
- Beard Alopecia: An Updated and Comprehensive Review of Etiologies, Presentation and Treatment
- Baricitinib: A Review in Severe Alopecia Areata
- Cytokine-targeted treatment in alopecia areata - new possibilities?
- A Case of Tofacitinib for the Treatment of Resistant Vitiligo and Sustained Repigmentation After Discontinuation
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis